DiaMedica Therapeutics Inc. (DMAC) Earnings
|
Expand Research on DMAC
| Next EPS Date | 8/12/26 | EPS Growth Rate | -5.6% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +6.6% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | -$0.19 | -$0.19 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 3/30/26 |
Q425 | N/A | -$0.18 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 | Q325 | -$0.17 | -$0.17 | $0.00 | N/A | N/A | N/A | | | Details | |
| 11/7/25 |
Q325 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/5/25 |
Q325 | N/A | -$0.17 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/12/25 | Q225 | -$0.18 | -$0.19 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 5/13/25 | Q125 | -$0.18 | -$0.20 | +$0.02 | N/A | N/A | N/A | | | Details |
